Suda Goki 須田剛生

… Alternative Names

SUDA Goki 須田剛生

Less

Researcher Number	20447460
Other IDs
External Links
Affiliation (Current)	2025: 北海道大学, 医学研究院, 講師
Affiliation (based on the past Project Information) *help	2022 – 2025: 北海道大学, 医学研究院, 講師 2017 – 2023: 北海道大学, 大学病院, 特任助教 2015 – 2016: 北海道大学, 医学研究科, 特任助教 2013 – 2015: 北海道大学, 医学(系)研究科(研究院), 特任助教 2014: 北海道大学, 医学(系)研究科(研究院), その他
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related / Gastroenterology Except Principal Investigator Basic Section 53010:Gastroenterology-related / Gastroenterology / Medium-sized Section 53:Organ-based internal medicine and related fields / Medium-sized Section 52:General internal medicine and related fields
Keywords	Principal Investigator HBV / miRNA / 肝線維化 / ドラッグスクリーニング / ハイスループット / IFN / 大規模スクリーニング / 抗HBV薬 / レポーター / 創薬 … More / drug screening / スクリーニング / ＨＢｘ / 癌 / 肝癌幹細胞 / CSCｓ / インテグレーション / HBｘ / 肝細胞癌 / truncated HBx / HBx / HCC / HCV / 薬剤耐性ウイルス / ＩＦＮ / ＨＣＶ … More Except Principal Investigator 肝線維化 / HCC / 癌幹細胞 / 肝癌幹細胞 / 免疫チェックポイント阻害剤 / HBx / B型肝炎ウイルス / 薬剤耐性 / 内科 / C型肝炎 / 肝発癌 / CXCL9 / FGFR4 / polygenic risk score / hepatocellular carcinoma / hepatitis B virus / Lenvatinib / がん幹細胞 / PARP阻害剤 / 肝細胞癌 / 食道扁平上皮癌 / 免疫寛容 / cancer stem like cells / 腫瘍免疫 / 肝がん / FGF / 肝癌 / HBx蛋白 / HBc抗原 / HBs抗原 / 宿主制限因子 / 宿主因子 / HBV / バイオマーカー / NAFLD / 糖鎖マーカー / 糖鎖 / NASH / 糖鎖修飾 / 完全排除 / DDB1 / cccDNA / HBV cccDNA / 医学 / DAA薬剤耐性 / ウイルス肝炎 / 間葉系幹細胞 / 間葉系幹細胞 / 肝線維症 / 肝硬変 / 消化器内科 / カルニチン / 肝脂肪化 / HCV / 薬剤耐性変異 / 抗ウイルス療法 / 分子動力学シミュレーション / 肝炎ウイルス / ウイルス学 Less

新規肝癌腫瘍免疫逃避機構・免疫チェックポイント阻害剤耐性化機構の解明と治療応用Principal Investigator
- Principal Investigator
  
  須田剛生
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
PRSによるB型肝炎関連肝がんの発症リスク予測
- Principal Investigator
  
  西田奈央
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Tokyo Medical and Dental University
肝癌のFGFR4-CXCL9 axis を介した免疫チェックポイント阻害剤耐性化機構の解析
- Principal Investigator
  
  荘拓也
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Development of novel CAR-T therapy targeting hepatic stellate cell-specific oligosaccharide antigens
- Principal Investigator
  
  坂本直哉
- Project Period (FY)
  2024 – 2025
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 52:General internal medicine and related fields
- Research Institution
  Hokkaido University
食道扁平上皮癌がん幹細胞における免疫逃避機構の解明
- Principal Investigator
  
  夏井坂光輝
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
PARP inhibitor resistance in cancer stem cells in hepatocelular carcinoma
- Principal Investigator
  
  小松嘉人
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
肝線維化治療標的同定とそれに基づく新規抗肝線維化治療法開発Principal Investigator
- Principal Investigator
  
  須田剛生
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Comprehensive search for host factors related to liver fibrosis mechanisms and development of novel therapeutic strategies
- Principal Investigator
  
  坂本直哉
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Elucidation of Maintenance and Immune Tolerance Mechanisms in hepatocellular carcinoma Stem Cells and Optimization of Therapeutic Approaches
- Principal Investigator
  
  Sho Takuya
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Glycan Modification Analysis as a Novel Diagnostic Marker and Therapeutic Target for Non-Alcoholic Fatty Liver Disease
- Principal Investigator
  
  Ogawa Koji
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Development of novel antiviral therapy targeting hepatitis B virus host restriction factor
- Principal Investigator
  
  Morikawa Kenichi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Targeting the glycosylated structure of liver tissue stromal proteins to form the basis for glycosylation drug discovery for liver fibrosis.
- Principal Investigator
  
  Sakamoto Naoya
- Project Period (FY)
  2020 – 2021
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 53:Organ-based internal medicine and related fields
- Research Institution
  Hokkaido University
High through anti-HBV drug screening by using reporter assayPrincipal Investigator
- Principal Investigator
  
  Suda Goki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Comprehensive screening of miviroenvirinmental factors that affect liver fibrosis
- Principal Investigator
  
  Sakamoto Naoya
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Hokkaido University
Development of drugs targeting liver fibrosis by modulation of protein/lipid glycosylation
- Principal Investigator
  
  Sakamoto Naoya
- Project Period (FY)
  2018 – 2019
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 53:Organ-based internal medicine and related fields
- Research Institution
  Hokkaido University
A new development of antivirals for eradication of HBV cccDNA
- Principal Investigator
  
  Morikawa Kenichi
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University
Search for new cell- or small molecule-based therapies to promote regression of liver cirrohsis
- Principal Investigator
  
  Sakamoto Naoya
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University
Effect of truncated Hepatitis B virus X protein integration on malignant potential of HCCPrincipal Investigator
- Principal Investigator
  
  Goki Suda
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University
Application of molecular dynamics simulation to construct of virtual assay system of antiviral drug resistance
- Principal Investigator
  
  Sakamoto Naoya
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University
Anti-Adipogenic and Antiviral Effects of L-Carnitine on Hepatitis C Virus Infection
- Principal Investigator
  
  koji ogawa
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University
Establishment of virtual assay system by molecular dynamic simulation of HCV antiviral resistance
- Principal Investigator
  
  Sakamoto Naoya
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University
To analyze the mechanisms of HCV drug resistance by using chimeric HCV cell culture systemPrincipal Investigator
- Principal Investigator
  
  SUDA Goki
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Hokkaido University

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

All Journal Article Presentation

[Journal Article] Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma2024
- Author(s)
  Camera Silvia、Rimini Margherita、Rossari Federico、Tada Toshifumi、Suda Goki、Cascinu Stefano、Casadei-Gardini Andrea
- Journal Title
  
  Targeted Oncology
  
  Volume: 19 Issue: 1 Pages: 29-39
- DOI
  10.1007/s11523-023-01029-6
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-21K07184
[Journal Article] Coexistence of muscle atrophy and high subcutaneous adipose tissue radiodensity predicts poor prognosis in hepatocellular carcinoma2023
- Author(s)
  Ohara Masatsugu、Suda Goki、Kohya Risako、Sasaki Takashi、Yoda Tomoka、Yoshida Sonoe、Fu Qingjie、Yang Zijian、Hosoda Shunichi、Maehara Osamu、Ohnishi Shunsuke、Tokuchi Yoshimasa、Kitagataya Takashi、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  Frontiers in Nutrition
  
  Volume: 10 Pages: 1-10
- DOI
  10.3389/fnut.2023.1272728
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K16008, KAKENHI-PROJECT-23K14998, KAKENHI-PROJECT-23K14999, KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-21K07953
[Journal Article] Neutrophil gelatinase-associated lipocalin predicts the efficacy of tolvaptan for ascites in patients with liver cirrhosis2023
- Author(s)
  Nakai Masato、Morikawa Kenichi、Sasaki Takashi、Kohya Risako、Yoshida Sonoe、Hosoda Shunichi、Kubo Akinori、Tokuchi Yoshimasa、Kitagataya Takashi、Yamada Ren、Ohara Masatsugu、Sho Takuya、Suda Goki、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 58 Issue: 7 Pages: 656-667
- DOI
  10.1007/s00535-023-01993-w
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07953
[Journal Article] Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma2023
- Author(s)
  Yang Zijian、Suda Goki、Maehara Osamu、Ohara Masatsugu、Yoda Tomoka、Sasaki Takashi、Kohya Risako、Yoshida Sonoe、Hosoda Shunichi、Tokuchi Yoshimasa、Kitagataya Takashi、Suzuki Kazuharu、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Ogawa Koji、Ohnishi Shunsuke、Sakamoto Naoya
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 3 Pages: 593-593
- DOI
  10.3390/cancers15030593
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17039
[Journal Article] Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients2023
- Author(s)
  Rimini M, Persano M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Presa J, Salani F, Lonardi S, Piscaglia F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Schirripa M, Montes M, Vivaldi C, Solda C, Hiraoka A, Sho T, Niizeki T, Nishida N, et al.
- Journal Title
  
  Journal of Cancer Research and Clinical Oncology
  
  Volume: ー Issue: 10 Pages: 7565-7577
- DOI
  10.1007/s00432-023-04678-2
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07950, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-21K07184, KAKENHI-PROJECT-21K08008
[Journal Article] Simultaneous determination of heparan sulfate, chondroitin/dermatan sulfates, and hyaluronan glycosaminoglycan disaccharides by high-performance liquid chromatography using a reverse-phase column with adamantyl groups2023
- Author(s)
  Hanamatsu Hisatoshi、Makino Satoshi、Ohara Masatsugu、Suda Goki、Yokota Ikuko、Nishihara Shoko、Sakamoto Naoya、Furukawa Jun-ichi
- Journal Title
  
  Journal of Chromatography A
  
  Volume: 1689 Pages: 463748-463748
- DOI
  10.1016/j.chroma.2022.463748
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24759, KAKENHI-PROJECT-23K24311
[Journal Article] Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma2023
- Author(s)
  Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, Morizane C, Karasic TB, Abrams TA, Furuse J, Kelley RK, Cassier PA, Klumpen HJ, Chang HM, Chen LT, Tabernero J, Oh DY, Mahipal A, Moehler M, Mitchell EP, Komatsu Y, Masuda K, Ahn D, Epstein RS, Halim AB, Fu Y, Salimi T, Wacheck V, He Y, Bridgewater JA
- Journal Title
  
  New England Journal of Medicine
  
  Volume: 388 Issue: 3 Pages: 228-239
- DOI
  10.1056/nejmoa2206834
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08023
[Journal Article] Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus2023
- Author(s)
  Tahata Yuki、Hikita Hayato、Suda Goki et al.,
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 58 Issue: 12 Pages: 1211-1221
- DOI
  10.1007/s00535-023-02039-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-23K07433, KAKENHI-PROJECT-21K19476, KAKENHI-PROJECT-23K24315, KAKENHI-PROJECT-23K24322
[Journal Article] Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C2023
- Author(s)
  Kawagishi Naoki、Suda Goki、Yamamoto Yoshiya、Baba Masaru、Furuya Ken、Maehara Osamu、Ohnishi Shunsuke、Yoshida Sonoe、Fu Qingjie、Yang Zijian、Hosoda Shunichi、Tokuchi Yoshimasa、Kitagataya Takashi、Ohara Masatsugu、Suzuki Kazuharu、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  Viruses
  
  Volume: 15 Issue: 1 Pages: 181-181
- DOI
  10.3390/v15010181
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-23K24311
[Journal Article] Hepatitis C virus eradication by direct‐acting antivirals causes a simultaneous increase in the prevalence of fatty liver and hyper low‐density lipoprotein cholesterolemia without an increase in body weight2023
- Author(s)
  Tokuchi Yoshimasa、Sho Takuya et al.,
- Journal Title
  
  Hepatology Research
  
  Volume: in press Issue: 7 Pages: 595-606
- DOI
  10.1111/hepr.13899
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-23K24311
[Journal Article] Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan2023
- Author(s)
  Sasaki Takashi、Kawagishi Naoki、et.al.,
- Journal Title
  
  Hepatology Research
  
  Volume: 53 Issue: 10 Pages: 960-967
- DOI
  10.1111/hepr.13936
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K14998, KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-21K07953
[Journal Article] Potential Correlation between Changes in Serum FGF21 Levels and Lenvatinib-Induced Appetite Loss in Patients with Unresectable Hepatocellular Carcinoma2023
- Author(s)
  Kohya Risako、Suda Goki、Kawagishi Naoki、et.al.,
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 12 Pages: 3257-3257
- DOI
  10.3390/cancers15123257
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K14998, KAKENHI-PROJECT-23K14999, KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-23K24311
[Journal Article] Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in hepatocellular carcinoma patients2023
- Author(s)
  Persano Mara、Rimini Margherita、Tada Toshifumi、Suda Goki、Shimose Shigeo、Kudo Masatoshi、Cheon Jaekyung、Masi Gianluca、Yoo Changhoon、Lonardi Sara、Tovoli Francesco、Kumada Takashi、Sakamoto Naoya、Tamburini Emiliano、Cabibbo Giuseppe、Foschi Francesco Giuseppe、Scartozzi Mario、Casadei-Gardini Andrea
- Journal Title
  
  European Journal of Cancer
  
  Volume: 189 Pages: 112933-112933
- DOI
  10.1016/j.ejca.2023.05.021
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08023, KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-21K07184
[Journal Article] Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis2023
- Author(s)
  Suda Goki、et al.,
- Journal Title
  
  Journal of Medical Virology
  
  Volume: 95 Issue: 2
- DOI
  10.1002/jmv.28452
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population.2022
- Author(s)
  Casadei-Gardini A, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Rimassa L, Presa J, Masi G, Yoo C, Lonardi S, Tovoli F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Pressiani T, Montes M, Vivaldi C, Solda C, Piscaglia F, Hiraoka A, Nishida N, et al.
- Journal Title
  
  European journal of cancer
  
  Volume: 180 Pages: 9-20
- DOI
  10.1016/j.ejca.2022.11.017
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-21K07184, KAKENHI-PROJECT-21K07950, KAKENHI-PROJECT-21K08008, KAKENHI-PROJECT-22K08046
[Journal Article] Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy2022
- Author(s)
  Kawagishi Naoki、Suda Goki et al.,
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1
- DOI
  10.1038/s41598-022-21315-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08046, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Small-molecule inhibitor cocktail promotes the proliferation of pre-existing liver progenitor cells2022
- Author(s)
  Fu Qingjie、Ohnishi Shunsuke、Suda Goki、Sakamoto Naoya
- Journal Title
  
  Stem Cell Reports
  
  Volume: 17 Issue: 7 Pages: 1589-1603
- DOI
  10.1016/j.stemcr.2022.05.023
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-23K24311
[Journal Article] Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication2022
- Author(s)
  Nakai Masato、Yamamoto Yoshiya、Baba Masaru、Suda Goki、Kubo Akinori、Tokuchi Yoshimasa、Kitagataya Takashi、Yamada Ren、Shigesawa Taku、Suzuki Kazuharu、Nakamura Akihisa、Sho Takuya、Morikawa Kenichi、Ogawa Koji、Furuya Ken、Sakamoto Naoya
- Journal Title
  
  Scientific Reports
  
  Volume: 12 Issue: 1 Pages: 1449-1449
- DOI
  10.1038/s41598-022-05492-5
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-23K24311
[Journal Article] Overestimated Renal Function in Patients with Liver Cirrhosis Predicts Poor Prognosis2022
- Author(s)
  Yoshida Sonoe、Suda Goki、et al.,
- Journal Title
  
  Hepatology Research
  
  Volume: in press Issue: 7 Pages: 603-613
- DOI
  10.1111/hepr.13765
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-22K16008, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008
[Journal Article] Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B2022
- Author(s)
  Suzuki Kazuharu、Suda Goki、Yamamoto Yoshiya、Abiko Satoshi、Kinoshita Kenji、Miyamoto Shuichi、Sugiura Ryo、Kimura Megumi、Maehara Osamu、Yamada Ren、Kitagataya Takashi、Shigesawa Taku、Ohara Masatsugu、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  PLOS ONE
  
  Volume: 17 Issue: 1 Pages: 261760-261760
- DOI
  10.1371/journal.pone.0261760
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371
[Journal Article] The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease2022
- Author(s)
  Nakamura Akihisa、Yamamoto Koji、Sakamoto Naoya et al.
- Journal Title
  
  Hepatology Research
  
  Volume: - Issue: 6 Pages: 508-521
- DOI
  10.1111/hepr.13757
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-23K24311
[Journal Article] Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis2022
- Author(s)
  Tahata Y, Hikita H, Mochida S, Enomoto N, Kawada N, Kurosaki M, Ido A, Miki D, Yoshiji H, Takikawa Y, Sakamori R, Hiasa Y, Nakao K, Kato N, Ueno Y, Yatsuhashi H, Itoh Y, Tateishi R, Suda G, Takami T, Nakamoto Y, Asahina Y, et al.
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 57 Issue: 2 Pages: 120-132
- DOI
  10.1007/s00535-021-01845-5
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08415, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-21K07909, KAKENHI-PROJECT-19H03635, KAKENHI-PROJECT-19H03637, KAKENHI-PROJECT-21H02896, KAKENHI-PROJECT-17K09435, KAKENHI-PROJECT-20K08314, KAKENHI-PROJECT-21K07894, KAKENHI-PROJECT-21K19476, KAKENHI-PROJECT-23K24315
[Journal Article] Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma2022
- Author(s)
  Yang Zijian、Suda Goki、et al.,
- Journal Title
  
  Cancers
  
  Volume: 14 Issue: 1 Pages: 232-232
- DOI
  10.3390/cancers14010232
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17039, KAKENHI-PROJECT-23K24311
[Journal Article] Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection2021
- Author(s)
  Suzuki K, Suda G, Yamamoto Y, Furuya K, Baba M, Nakamura A, Miyoshi H, Kimura M, Maehara O, Yamada R, Kitagataya T, Yamamoto K, Shigesawa T, Nakamura A, Ohara M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Sakamoto N
- Journal Title
  
  J Gastroenterol.
  
  Volume: 56 Issue: 2 Pages: 168-180
- DOI
  10.1007/s00535-020-01750-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-19H03630
[Journal Article] Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma2021
- Author(s)
  Shigesawa T, Suda G, Kimura M, Maehara O, Tokuchi Y, Kubo A, Yamada R, Furuya K, Baba M, Kitagataya T, Suzuki K, Ohara M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.
- Journal Title
  
  PLoS One
  
  Volume: 16(3) Issue: 3 Pages: e0247728-e0247728
- DOI
  10.1371/journal.pone.0247728
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-20K17039, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630
[Journal Article] FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinoma2021
- Author(s)
  Maehara Osamu、Suda Goki、Natsuizaka Mitsuteru、Shigesawa Taku、Kanbe Gouki、Kimura Megumi、Sugiyama Masaya、Mizokami Masashi、Nakai Masato、Sho Takuya、Morikawa Kenichi、Ogawa Koji、Ohashi Shinya、Kagawa Shingo、Kinugasa Hideaki、Naganuma Seiji、Okubo Naoto、Ohnishi Shunsuke、Takeda Hiroshi、Sakamoto Naoya
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 22 Issue: 5-6 Pages: 372-380
- DOI
  10.1080/15384047.2021.1939638
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17039
[Journal Article] Genomic profiling of intestinal/mixed‐type superficial non‐ampullary duodenal epithelial tumors2021
- Author(s)
  Miyamoto Shuichi、Suda Goki、Ishikawa Marin、Hayashi Hideyuki、Nimura Satoshi、Matsuno Yoshihiro、Mori Ryo、Tanishima Shigeki、Kudo Takahiko、Takagi Tomofumi、Yamamoto Yoshiya、Ono Shoko、Shimizu Yuichi、Sakamoto Naoya
- Journal Title
  
  JGH Open
  
  Volume: 5 Issue: 9 Pages: 1071-1077
- DOI
  10.1002/jgh3.12632
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458
[Journal Article] Changes in the estimated renal function after hepatitis C virus eradication with direct-acting antiviral agents: Impact of changes in skeletal muscle mass2021
- Author(s)
  Tokuchi Y, Suda G, Kimura M, Maehara O, Kitagataya T, Ohara M, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.
- Journal Title
  
  J Viral Hepat.
  
  Volume: in press Issue: 5 Pages: 755-763
- DOI
  10.1111/jvh.13484
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C2021
- Author(s)
  Kawagishi Naoki、Suda Goki、Kimura Megumi、Maehara Osamu、Yamada Ren、Tokuchi Yoshimasa、Kubo Akinori、Kitagataya Takashi、Shigesawa Taku、Suzuki Kazuharu、Ohara Masatsugu、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Sakamoto Naoya
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 9207-9207
- DOI
  10.1038/s41598-021-88632-7
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy2021
- Author(s)
  Sho Takuya、Morikawa Kenichi、Kubo Akinori、Tokuchi Yoshimasa、Kitagataya Takashi、Yamada Ren、Shigesawa Taku、Kimura Mugumi、Nakai Masato、Suda Goki、Natsuizaka Mitsuteru、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  World Journal of Gastrointestinal Oncology
  
  Volume: 13 Issue: 12 Pages: 2076-2087
- DOI
  10.4251/wjgo.v13.i12.2076
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953
[Journal Article] Recent advances in the treatment of hepatitis C virus infection for special populations and remaining problems2021
- Author(s)
  Suda G, Sakamoto N
- Journal Title
  
  J Gastroenterol Hepatol.
  
  Volume: in press Issue: 5 Pages: 1152-1158
- DOI
  10.1111/jgh.15189
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458
[Journal Article] Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib2021
- Author(s)
  Rimini M.、Kudo M.、Tada T.、Shigeo S.、Kang W.、Suda G.、et al.,
- Journal Title
  
  ESMO Open
  
  Volume: 6 Issue: 6 Pages: 100330-100330
- DOI
  10.1016/j.esmoop.2021.100330
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08458
[Journal Article] Possible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals2021
- Author(s)
  Tokuchi Yoshimasa、Suda Goki、et al.,
- Journal Title
  
  Scientific Reports
  
  Volume: 11 Issue: 1 Pages: 16616-16616
- DOI
  10.1038/s41598-021-96203-z
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371
[Journal Article] Frequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia2021
- Author(s)
  Yoshida Sonoe、Suda Goki、et al.,
- Journal Title
  
  Nutrients
  
  Volume: 13 Issue: 7 Pages: 2415-2415
- DOI
  10.3390/nu13072415
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K08371
[Journal Article] Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report2021
- Author(s)
  Umemura Machiko、Suda Goki、Tsukamoto Shihori、Ebata Ko、Takahash Shinjiro、Sasaki Takashi、Nakajima Sae、Hirata Koji、Ozasa Mariko、Takano Masatoshi、Katagiri Masaki、Sakamoto Naoya
- Journal Title
  
  BMC Infectious Diseases
  
  Volume: 21 Issue: 1
- DOI
  10.1186/s12879-021-06091-x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458
[Journal Article] Characteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI2021
- Author(s)
  Kubo Akinori、Suda Goki、Kimura Megumi、Maehara Osamu、Tokuchi Yoshimasa、Kitagataya Takashi、Ohara Masatsugu、Yamada Ren、Shigesawa Taku、Suzuki Kazuharu、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Ohnishi Shunsuke、Sakamoto Naoya
- Journal Title
  
  Cancers
  
  Volume: 13 Issue: 14 Pages: 3633-3633
- DOI
  10.3390/cancers13143633
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-20K17039
[Journal Article] Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria2021
- Author(s)
  Sho Takuya、Suda Goki、et al.,
- Journal Title
  
  Hepatology Research
  
  Volume: 51 Issue: 9 Pages: 979-989
- DOI
  10.1111/hepr.13693
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-21K07953, KAKENHI-PROJECT-20K17008
[Journal Article] Time-dependent changes in the seroprevalence of COVID-19 in asymptomatic liver disease outpatients in an area in Japan undergoing a second wave of COVID-192020
- Author(s)
  Suda G, Ogawa K, Kimura M, Maehara O, Kitagataya T, Ohara M, Tokuchi Y, Kubo A, Yamada R, Shigesawa T, Suzuki K, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Sakamoto N.
- Journal Title
  
  Hepatol Res.
  
  Volume: 5- Issue: 10 Pages: 1196-1200
- DOI
  10.1111/hepr.13551
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371
[Journal Article] Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma2020
- Author(s)
  Shigesawa Taku、Suda Goki、Kimura Megumi、Shimazaki Tomoe、Maehara Osamu、Yamada Ren、Kitagataya Takashi、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Umemura Machiko、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  JGH Open
  
  Volume: 4 Issue: 5 Pages: 880-888
- DOI
  10.1002/jgh3.12339
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-19H03630
[Journal Article] Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people.2020
- Author(s)
  Ohara M, Suda G, Kimura M, Maehara O, Shimazaki T, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Kobayashi T, Uebayashi M, Takagi R, Yokota I, Shimamura T, Sakamoto N.
- Journal Title
  
  Hepatol Res
  
  Volume: in press Issue: 6 Pages: 715-725
- DOI
  10.1111/hepr.13499
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-18K19530, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371
[Journal Article] High serum angiopoietin‐2 level predicts non‐regression of liver stiffness measurement‐based liver fibrosis stage after direct‐acting antiviral therapy for hepatitis C2020
- Author(s)
  Kawagishi Naoki、Suda Goki、Kimura Megumi、Maehara Osamu、Shimazaki Tomoe、Yamada Ren、Kitagataya Takashi、Shigesawa Taku、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Umemura Machiko、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Sakamoto Naoya
- Journal Title
  
  Hepatology Research
  
  Volume: in press Issue: 6 Pages: 671-681
- DOI
  10.1111/hepr.13490
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-18K07959, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K21592, KAKENHI-PROJECT-20K17008, KAKENHI-PROJECT-19H03630
[Journal Article] Durable response without recurrence to Tolvaptan improves long-term survival2020
- Author(s)
  Nakai M, Suda G, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Ohara M, Umemura M, Sho T, Morikawa K, Ogawa K, Sakamoto N.
- Journal Title
  
  J Gastroenterol.
  
  Volume: 55 Issue: 12 Pages: 1150-1161
- DOI
  10.1007/s00535-020-01721-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298, KAKENHI-PROJECT-20K08371
[Journal Article] Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling2020
- Author(s)
  Shigesawa Taku、Morikawa Kenichi et al.
- Journal Title
  
  Carcinogenesis
  
  Volume: 42 Issue: 1 Pages: 58-69
- DOI
  10.1093/carcin/bgaa049
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08371, KAKENHI-PROJECT-20K17039, KAKENHI-PROJECT-19H03630
[Journal Article] Tri-antennary tri-sialylated mono-fucosylated glycan of alpha-1 antitrypsin as a non-invasive biomarker for non-alcoholic steatohepatitis: a novel glycobiomarker for non-alcoholic steatohepatitis2020
- Author(s)
  Ogawa Koji、Kobayashi Takashi、Furukawa Jun-ichi、Hanamatsu Hisatoshi、Nakamura Akihisa、Suzuki Kazuharu、Kawagishi Naoki、Ohara Masatsugu、Umemura Machiko、Nakai Masato、Sho Takuya、Suda Goki、Morikawa Kenichi、Sakamoto Naoya et al.
- Journal Title
  
  Scientific Reports
  
  Volume: 10 Issue: 1 Pages: 321-321
- DOI
  10.1038/s41598-019-56947-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-20K21592
[Journal Article] Prevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan.2020
- Author(s)
  Kitagataya T, Suda G, Nagashima K, Katsurada T, Yamamoto K, Kimura M, Maehara O, Yamada R, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Umemura M, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Ohnishi S, Komatsu Y, Hata H, Takeuchi S, Abe T, Sakakibara-Konishi J, Teshima T, Homma A, Sakamoto N.
- Journal Title
  
  J Gastroenterol Hepatol
  
  Volume: in press Issue: 10 Pages: 1782-1788
- DOI
  10.1111/jgh.15041
- NAID
  120007160309
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-20K08298
[Journal Article] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection2019
- Author(s)
  Suda Goki
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: in press Issue: 7 Pages: 641-649
- DOI
  10.1007/s00535-019-01556-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09334
[Journal Article] Quantifying Protein-Specific N-Glycome Profiles by Focused Protein and Immunoprecipitation Glycomics2019
- Author(s)
  Kobayashi Takashi、Ogawa Koji、Furukawa Jun-ichi、Hanamatsu Hisatoshi、Hato Megumi、Yoshinaga Tomoyo、Morikawa Kenichi、Suda Goki、Sho Takuya、Nakai Masato、Higashino Kenichi、Numata Yoshito、Shinohara Yasuro、Sakamoto Naoya
- Journal Title
  
  Journal of Proteome Research
  
  Volume: 18 Issue: 8 Pages: 3133-3141
- DOI
  10.1021/acs.jproteome.9b00232
- NAID
  120006876288
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19H03630, KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-18K19530, KAKENHI-PROJECT-16K19324
[Journal Article] Comparative Glycomic Analysis of Sialyl Linkage Isomers by Sialic Acid Linkage-Specific Alkylamidation in Combination with Stable Isotope Labeling of α2,3-Linked Sialic Acid Residues2019
- Author(s)
  Hanamatsu Hisatoshi、Nishikaze Takashi、Tsumoto Hiroki、Ogawa Koji、Kobayashi Takashi、Yokota Ikuko、Morikawa Kenichi、Suda Goki、Sho Takuya、Nakai Masato、Miura Nobuaki、Higashino Kenichi、Sekiya Sadanori、Iwamoto Shinichi、Miura Yuri、Furukawa Jun-ichi、Tanaka Koichi、Sakamoto Naoya
- Journal Title
  
  Analytical Chemistry
  
  Volume: 91 Issue: 21 Pages: 13343-13348
- DOI
  10.1021/acs.analchem.9b03617
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07025, KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-19K15597, KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-18K19530, KAKENHI-PROJECT-16K19324
[Journal Article] Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis2019
- Author(s)
  Suzuki Kazuharu、Suda Goki、Yamamoto Yoshiya、Furuya Ken、Baba Masaru、Kimura Megumi、Maehara Osamu、Shimazaki Tomoe、Yamamoto Koji、Shigesawa Taku、Nakamura Akihisa、Ohara Masatsugu、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya、for the NORTE Study Group
- Journal Title
  
  Hepatology Research
  
  Volume: 49 Issue: 11 Pages: 1294-1304
- DOI
  10.1111/hepr.13399
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K19324
[Journal Article] Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three Cases2019
- Author(s)
  Sho Takuya、Suda Goki、Kimura Megumi、Shimazaki Tomoe、Maehara Osamu、Shigesawa Taku、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Umemura Machiko、Izumi Takaaki、Kawagishi Naoki、Baba Masaru、Nakai Masato、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya、for the NORTE Study Group
- Journal Title
  
  Intern. Med.
  
  Volume: 58 Issue: 6 Pages: 797-802
- DOI
  10.2169/internalmedicine.1856-18
- NAID
  130007611402
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2019-03-15
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K19324
[Journal Article] Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter2019
- Author(s)
  Izumi Takaaki、Sho Takuya、Morikawa Kenichi、Shigesawa Taku、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Kawagishi Naoki、Umemura Machiko、Shimazaki Tomoe、Kimura Megumi、Nakai Masato、Suda Goki、Natsuizaka Mitsuteru、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Ono Kota、Baba Masaru、Furuya Ken、Sakamoto Naoya
- Journal Title
  
  Hepatology Research
  
  Volume: 49 Issue: 10 Pages: 1207-1217
- DOI
  10.1111/hepr.13391
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K19324
[Journal Article] Effects of resistance-associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs.2019
- Author(s)
  Suda G, Kimura M, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Kawagishi N, Nakai M, Sho T, Maehara O, Shimazaki T, Morikawa K, Natsuizaka M, Ogawa K, Sakamoto N.
- Journal Title
  
  Hepatol Res
  
  Volume: 49 Issue: 11 Pages: 1275-1285
- DOI
  10.1111/hepr.13401
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08458, KAKENHI-PROJECT-17K09400
[Journal Article] Correlation between Liver Elasticity by Ultrasound Elastography and Liver Functional Reserve2019
- Author(s)
  Sugiura Ryo、Kuwatani Masaki、Nishida Mutsumi、Hirata Koji、Sano Itsuki、Kato Shin、Kawakubo Kazumichi、Nakai Masato、Sho Takuya、Suda Goki、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya
- Journal Title
  
  Ultrasound in Medicine & Biology
  
  Volume: 45 Issue: 10 Pages: 2704-2712
- DOI
  10.1016/j.ultrasmedbio.2019.06.407
- NAID
  120006887711
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400
[Journal Article] The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment2019
- Author(s)
  Suda Goki、Nakai Masato、Sho Takuya、Kimura Megumi、Shimazaki Tomoe、Maehara Osamu、Shigesawa Taku、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Umemura Machiko、Kawagishi Naoki、Baba Masaru、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya、for the NORTE Study Group
- Journal Title
  
  Intern. Med.
  
  Volume: 58 Issue: 7 Pages: 943-947
- DOI
  10.2169/internalmedicine.2077-18
- NAID
  130007622183
- ISSN
  0918-2918, 1349-7235
- Year and Date
  2019-04-01
- Language
  English
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K09334
[Journal Article] Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats2018
- Author(s)
  Ohara Masatsugu、Ohnishi Shunsuke、Hosono Hidetaka、Yamamoto Koji、Yuyama Kohei、Nakamura Hideki、Fu Qingjie、Maehara Osamu、Suda Goki、Sakamoto Naoya
- Journal Title
  
  Stem Cells International
  
  Volume: 2018 Pages: 1-15
- DOI
  10.1155/2018/3212643
- NAID
  120006585982
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06456, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-17J00434, KAKENHI-PROJECT-16K09334
[Journal Article] Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis2018
- Author(s)
  3.Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N
- Journal Title
  
  Hepatolgy Research
  
  Volume: in press Issue: 3
- DOI
  10.1111/hepr.12988
- NAID
  120006551584
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K19324, KAKENHI-PROJECT-16H05282
[Journal Article] Palmitoylethanolamide Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis in Rats.2018
- Author(s)
  Ohara M, Ohnishi S, Hosono H, Yamamoto K, Fu Q, Maehara O, Suda G, Sakamoto N
- Journal Title
  
  Front Pharmacol
  
  Volume: 9 Pages: 709-709
- DOI
  10.3389/fphar.2018.00709
- NAID
  120006522665
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-17J00434
[Journal Article] Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction2018
- Author(s)
  Sho T, Suda G,, Nagasaka A, Yamamoto Y, Furuya K, Kumagai K, Uebayashi M, Terashita K, Kobayashi T, Tsunematsu I, Onodera M, Meguro T, Kimura M, Ito J, Umemura M, Izumi T, Kawagishi N, Ohara M, Ono Y, Nakai M, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  Heptology Research
  
  Volume: in press Issue: 7 Pages: 529-538
- DOI
  10.1111/hepr.13056
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K15420
[Journal Article] Treatment of hepatitis C in special populations.2018
- Author(s)
  Suda G, Ogawa K, Morikawa K, Sakamoto N
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: in press Issue: 5 Pages: 591-605
- DOI
  10.1007/s00535-017-1427-x
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-15K08980
[Journal Article] Macrophage-Derived Extracellular Vesicles Induce Long-Lasting Immunity Against Hepatitis C Virus Which Is Blunted by Polyunsaturated Fatty Acids.2018
- Author(s)
  Cai C, Koch B, Morikawa K, Suda G, Sakamoto N, Rueschenbaum S, Akhras S, Dietz J, Hildt E, Zeuzem S, Welsch C, Lange CM
- Journal Title
  
  Front Immunol
  
  Volume: 9 Pages: 723-723
- DOI
  10.3389/fimmu.2018.00723
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05282
[Journal Article] Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis.2018
- Author(s)
  3.Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N
- Journal Title
  
  Hepatology Research
  
  Volume: in press
- NAID
  120006551584
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980
[Journal Article] Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis2018
- Author(s)
  Kawagishi Naoki、Suda Goki、Nakamura Akinobu、Kimura Megumi、Maehara Osamu、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Izumi Takaaki、Umemura Machiko、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Miyoshi Hideaki、Sakamoto Naoya
- Journal Title
  
  PLOS ONE
  
  Volume: 13 Issue: 12 Pages: 615-620
- DOI
  10.1371/journal.pone.0209615
- NAID
  120006866533
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K19324, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-17J00434, KAKENHI-PROJECT-16K09334
[Journal Article] Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation2018
- Author(s)
  Matsuda Kana、Ono Shoko、Ishikawa Marin、Miyamoto Shuichi、Abiko Satoshi、Tsuda Momoko、Yamamoto Keiko、Kudo Takahiko、Shimizu Yuichi、Hayase Eiko、Hashimoto Daigo、Teshima Takanori、Matsuno Yoshihiro、Sakamoto Naoya
- Journal Title
  
  Annals of Hematology
  
  Volume: 97 Issue: 5 Pages: 877-883
- DOI
  10.1007/s00277-018-3241-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09945, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-17H04206
[Journal Article] L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis2018
- Author(s)
  Ohara Masatsugu、Ogawa Koji、Suda Goki、Kimura Megumi、Maehara Osamu、Shimazaki Tomoe、Suzuki Kazuharu、Nakamura Akihisa、Umemura Machiko、Izumi Takaaki、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ohnishi Shunsuke、Sakamoto Naoya
- Journal Title
  
  Hepatology Communications
  
  Volume: 2 Issue: 8 Pages: 906-918
- DOI
  10.1002/hep4.1207
- NAID
  120006585791
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K19324, KAKENHI-PROJECT-17J00434, KAKENHI-PROJECT-16K09334
[Journal Article] Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection2018
- Author(s)
  Suda Goki、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya、他
- Journal Title
  
  Journal of Gastroenterology
  
  Volume: 54 Issue: 1 Pages: 78-86
- DOI
  10.1007/s00535-018-1495-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K19324
[Journal Article] A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma2017
- Author(s)
  Sho Takuya、Nakanishi Mitsuru、Morikawa Kenichi、Ohara Masatsugu、Kawagishi Naoki、Izumi Takaaki、Umemura Machiko、Ito Jun、Nakai Masato、Suda Goki、Ogawa Koji、Chuma Makoto、Meguro Takashi、Nakamura Michio、Nagasaka Atsushi、Horimoto Hiromasa、Yamamoto Yoshiya、Sakamoto Naoya
- Journal Title
  
  Drugs R D.
  
  Volume: 17 Issue: 3 Pages: 381-388
- DOI
  10.1007/s40268-017-0187-7
- NAID
  120006369333
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09400
[Journal Article] Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy2017
- Author(s)
  Suda G, Ogawa K, Yamamoto Y, Katagiri M, Furuya K, Kumagai K, Konno J, Kimura M, Kawagishi N, Ohara M, Umemura M, Ito J, Izumi T, Nakai M, Sho T, Natsuizaka M, Morikawa K, Tsubota A, Shimada N, Iio E, Tanaka Y, Sakamoto N; NORTE Study Group.
- Journal Title
  
  J Gastroenterol
  
  Volume: 印刷中 Issue: 10 Pages: 1122-1129
- DOI
  10.1007/s00535-017-1328-z
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-15K06810, KAKENHI-PROJECT-16K15420
[Journal Article] Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study2017
- Author(s)
  Suda Goki、Morikawa Kenichi、et al.
- Journal Title
  
  Hepatol Res.
  
  Volume: 48 Issue: 3
- DOI
  10.1111/hepr.12938
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K15420
[Journal Article] Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan2017
- Author(s)
  Suda Goki、Morikawa Kenichi、et al.
- Journal Title
  
  J Gastroenterol.
  
  Volume: 53 Issue: 1 Pages: 119-128
- DOI
  10.1007/s00535-017-1353-y
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-16K15420
[Journal Article] Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A.2017
- Author(s)
  Tsunematsu S, Suda G, Yamasaki K, Kimura M, Izumi T, Umemura M, Ito J, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, Tanaka Y, Watashi K, Wakita T, Sakamoto N
- Journal Title
  
  J Med Virol
  
  Volume: 89 Issue: 2 Pages: 267-275
- DOI
  10.1002/jmv.24643
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16K15420, KAKENHI-PROJECT-26460565
[Journal Article] Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C2017
- Author(s)
  Kawagishi N.、Suda G.、Onozawa M.、Kimura M.、Maehara O.、Ohara M.、Izumi T.、Umemura M.、Ito J.、Nakai M.、Sho T.、Natsuizaka M.、Morikawa K.、Ogawa K.、Sakamoto N.
- Journal Title
  
  J Viral Hepat.
  
  Volume: 24 Issue: 12 Pages: 1098-1106
- DOI
  10.1111/jvh.12737
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16K19324, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-17J00434, KAKENHI-PROJECT-16K15420
[Journal Article] Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report2017
- Author(s)
  Yoshikawa Ayumu、Terashita Katsumi、Morikawa Kenichi、Matsuda Soichiro、Yamamura Takahiro、Sarashina Koichiro、Nakano Shintaro、Kobayashi Yoshimitsu、Sogabe Susumu、Takahashi Kazuhiro、Haba Shin、Oda Hisashi、Takahashi Tatsuro、Miyagishima Takuto、Sakamoto Naoya
- Journal Title
  
  Clin J Gastroenterol.
  
  Volume: 10 Issue: 3 Pages: 270-273
- DOI
  10.1007/s12328-017-0742-3
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09400
[Journal Article] Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection2017
- Author(s)
  Kawagishi N, Suda G, Onozawa M, Kimura M, Maehara O, Ito J, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  Journal of Hepatology
  
  Volume: 67 Issue: 5 Pages: 1098-1106
- DOI
  10.1016/j.jhep.2017.04.008
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-17J00434
[Journal Article] Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma2017
- Author(s)
  Osamu Maehara, Goki Suda et al.
- Journal Title
  
  Carcinogenesis
  
  Volume: 38 Issue: 11 Pages: 1073-1083
- DOI
  10.1093/carcin/bgx095
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-17K09400, KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-17J00434, KAKENHI-PROJECT-15K08943
[Journal Article] Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus infected patients with renal impairment2017
- Author(s)
  Suda G, Nagasaka A, Yamamoto Y, Furuya K, Kumagai K, Kudo M, Terashita K, Kobayashi T, Tsunematsu I, Yoshida J, Meguro T, Kimura M, Ito J, Umemura M, Izumi T, Tsunematsu S, Sato F, Tsukuda Y, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.
- Journal Title
  
  Hepatol Res
  
  Volume: 印刷中 Issue: 11 Pages: 1127-1136
- DOI
  10.1111/hepr.12851
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16K15420
[Journal Article] Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study2017
- Author(s)
  5.Suda G, Ito J, Nagasaka A, Yamamoto Y, Furuya K, Okamoto M, Terashita K, Kobayashi T, Tsunematsu I, Yoshida J, Meguro T, Ohara M, Kawagishi N, Kimura M, Umemura M, Izumi T, Tsukuda Y, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  Hepatology Research
  
  Volume: 48
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980
[Journal Article] Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C.2016
- Author(s)
  Suda G, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kobayashi T, Shinada K, Tateyama M, Konno J, Tsukuda Y, Yamasaki K, Kimura M, Umemura M, Izumi T, Tsunematsu S, Sato F, Terashita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  J Gastroenterol Hepatol
  
  Volume: EPub Issue: 7 Pages: 733-740
- DOI
  10.1007/s00535-016-1162-8
- NAID
  120006313426
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08943
[Journal Article] Viral life cycle of hepatitis B virus : host factors and druggable targets.2016
- Author(s)
  Morikawa K, Suda G, Sakamoto N
- Journal Title
  
  Hepatol Res
  
  Volume: EPub Issue: 9 Pages: 871-877
- DOI
  10.1111/hepr.12650
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-16K15420
[Journal Article] Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.2016
- Author(s)
  Tsukuda Y, Suda G, Tsunematsu S, Ito J, Sato F, Terashita K, Nakai M, Sho T, Maehara O, Shimazaki T, Kimura M, Morikawa K, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Sakamoto N
- Journal Title
  
  J Med Virol
  
  Volume: 89 Issue: 5 Pages: 857-866
- DOI
  10.1002/jmv.24692
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-16H05282, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08943, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334, KAKENHI-PROJECT-16K15420
[Journal Article] Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C.2016
- Author(s)
  Suda G, Kudo M, Nagasaka A, Furuya K, Yamamoto Y, Kobayashi T, Shinada K, Tateyama M, Konno J, Tsukuda Y, Yamasaki K, Kimura M, Umemura M, Izumi T, Tsunematsu S, Sato F, Terashita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
- Journal Title
  
  J Gastroenterol
  
  Volume: in press
- NAID
  120006313426
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980
[Journal Article] Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment2016
- Author(s)
  Suda G, Ogawa K, Kimura M, Nakai M, Sho T, Morikawa K, Sakamoto N.
- Journal Title
  
  J Clin Transl Hepatol
  
  Volume: 4(4) Pages: 320-327
- DOI
  10.14218/jcth.2016.00032
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-16K09334
[Journal Article] Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection2016
- Author(s)
  Ito J, Suda G, Yamamoto Y, Nagasaka A, Furuya K, Kumagai K, Kikuchi H, Miyagishima T, Kobayashi T, Kimura M, Yamasaki K, Umemura M, Izumi T, Tsunematsu S, Sato F, Tsukuda Y, Terashita K, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto
- Journal Title
  
  Hepatol Res
  
  Volume: in press Issue: 13 Pages: 1294-1303
- DOI
  10.1111/hepr.12685
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-26461021, KAKENHI-PROJECT-16K15420
[Journal Article] Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma2015
- Author(s)
  Tsunematsu S, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N
- Journal Title
  
  Abdom Imaging
  
  Volume: 40 Issue: 6 Pages: 1492-9
- DOI
  10.1007/s00261-015-0352-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-26460982, KAKENHI-PROJECT-26461021
[Journal Article] EGFR inhibitors eliminate cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition2015
- Author(s)
  １．Fumiyuki Sato, Yoshimasa Kubota, Mitsuteru Natsuizaka, Osamu Maehara, Yutaka Hatanaka, Katsuji Marukawa, Katsumi Terashita, Goki Suda, Shunsuke Ohnishi, Yuichi Shimizu, Yoshito Komatsu, Shinya Ohashi, Shingo Kagawa, Hideaki Kinugasa, Kelly Whelan, Anil Rustgi, Hiroshi Nakagawa, and Naoya Sakamoto
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: Epub ahead of print
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25860513
[Journal Article] Human amnion-derived mesenchymeal stem cell transplantation ameliorates dextran sulfate sodium-induced severe colitis in rats.2015
- Author(s)
  ２．Onishi R, Ohnishi S, Higashi R, Watari M, Yamahara K, Okubo N, Nakagawa K, Katsurada T, Suda G, Natsuizaka M, Takeda H, Sakamoto N
- Journal Title
  
  Cell Transplantation
  
  Volume: Epub ahead of print
- NAID
  120005690898
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25860513
[Journal Article] Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma2015
- Author(s)
  ３．Tsunematsu S1, Chuma M, Kamiyama T, Miyamoto N, Yabusaki S, Hatanaka K, Mitsuhashi T, Kamachi H, Yokoo H, Kakisaka T, Tsuruga Y, Orimo T, Wakayama K, Ito J, Sato F, Terashita K, Nakai M, Tsukuda Y, Sho T, Suda G, Morikawa K, Natsuizaka M, Nakanishi M, Ogawa K, Taketomi A, Matsuno Y, Sakamoto N
- Journal Title
  
  Abdom Imaging.
  
  Volume: Epub ahead of print
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25860513
[Journal Article] Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions.2015
- Author(s)
  Suda G, Yamamoto Y, Nagasaka A, Furuya K, Kudo M, Chuganji Y, Tsukuda Y, Tsunematsu S, Sato F, Terasita K, Nakai M, Horimoto H, Sho T, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Fujita Y, Abe R, Taniguchi M, Nakagawa M, Asahina Y, Sakamoto N
- Journal Title
  
  Hepatol Res
  
  Volume: 印刷中 Issue: 8 Pages: 837-45
- DOI
  10.1111/hepr.12421
- NAID
  120005820706
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-24390185, KAKENHI-PROJECT-24590958, KAKENHI-PROJECT-24590960, KAKENHI-PROJECT-25293169, KAKENHI-PROJECT-25670366, KAKENHI-PROJECT-25860513, KAKENHI-PROJECT-26670375, KAKENHI-PROJECT-15K08980
[Journal Article] A pivotal role of Krüppel-like factor 5 in regulation of cancer stem-like cells in hepatocellular carcinoma.2015
- Author(s)
  Maehara O, Sato F, Natsuizaka M, Asano A, Kubota Y, Itoh J, Tsunematsu S, Terashita K, Tsukuda Y, Nakai M, Sho T, Suda G, Morikawa K, Ogawa K, Chuma M, Nakagawa K, Ohnishi S, Komatsu Y, Whelan KA, Nakagawa H, Takeda H, Sakamoto N.
- Journal Title
  
  Cancer Biol Ther
  
  Volume: 16 Issue: 10 Pages: 14531461-14531461
- DOI
  10.1080/15384047.2015.1070992
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K08943, KAKENHI-PROJECT-15K08980, KAKENHI-PROJECT-26460933, KAKENHI-PROJECT-26461021
[Journal Article] Telaprevir:副作用とその対策2014
- Author(s)
  須田剛生、坂本直哉
- Journal Title
  
  Internal Medicine
  
  Volume: ６７ Pages: 855-860
- Data Source
  KAKENHI-PROJECT-25860513
[Journal Article] Hepatosplenic Gamma-delta T-cell Lymphoma Associated with Epstein-Barr Virus2014
- Author(s)
  ６．Seiji Tsunematsu, Mitsuteru Natsuizaka, Hiromi Fujita, Noriyuki Otsuka, Katsumi Terashita, Fumiyuki Sato, Tomoe Kobayashi, Masato Nakai, Yoko Tsukuda, Hiromasa Horimoto, Takuya Sho, Goki Suda, Mitsuru Nakanishi, Satoshi Hashino, Makoto Chuma, Naoya Sakamoto
- Journal Title
  
  Intern Med
  
  Volume: 53(18) Pages: 2079-2082
- NAID
  130004687645
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25860513
[Journal Article] インターフェロン少量長期療法の実際と新薬時代における役割2014
- Author(s)
  須田剛生、坂本直哉
- Journal Title
  
  内科
  
  Volume: 113 Pages: 681-685
- Data Source
  KAKENHI-PROJECT-25860513
[Journal Article] Heat shock factor 1 accelerates hepatocellular carcinoma development by activating nuclear factor κB/mitogen-activated protein kinase.2014
- Author(s)
  Chuma M, Sakamoto N, Nakai A, Hige S, Nakanishi M, Natsuizaka M, Suda G, Sho T, Hatakaka K, Matsuno Y, Yokoo H, Kamiyama T, Taketomi A, Fujii G, Tashiro K, Hikiba Y, Fujimoto M, Asaka M, Maeda S
- Journal Title
  
  Carcinogenesis
  
  Volume: Epub ahead of print Issue: 2 Pages: 272-281
- DOI
  10.1093/carcin/bgt343
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24659359, KAKENHI-PROJECT-25440010, KAKENHI-PROJECT-25860512, KAKENHI-PROJECT-25860513, KAKENHI-PROJECT-26460982
[Journal Article] C型肝炎ウイルス蛋白によるシグナル伝達制御2013
- Author(s)
  須田剛生、坂本直哉
- Journal Title
  
  分子消化器病
  
  Volume: 10 Pages: 68-72
- Data Source
  KAKENHI-PROJECT-25860513
[Journal Article] IL6を介したC型慢性肝炎のインターフェロン治療抵抗性機構2013
- Author(s)
  須田剛生、坂本直哉
- Journal Title
  
  消化器内科
  
  Volume: 56 Pages: 421-426
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] 消化器癌に対する免疫療法の現状と課題　非切除肝細胞癌患者における複合的がん免疫療法における治療後獲得薬剤耐性化に伴ってみられる血清増殖因子変化の検討2023
- Author(s)
  須田剛生, 大原正嗣, 坂本直哉
- Organizer
  第27回　日本肝臓学会大会
- Data Source
  KAKENHI-PROJECT-22K08023
[Presentation] C型非代償性肝硬変のDAA治療:現状と課題　非代償性C型肝硬変患者を含むDAA治療後肝病態に影響する因子の検討2023
- Author(s)
  須田剛生, 川岸直樹, 坂本直哉
- Organizer
  第109回　日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-22K08023
[Presentation] B型慢性肝炎患者に対するTDFからTAF切り替え後の脂質代謝に与える影響の検討2022
- Author(s)
  鈴木和治, 山本義也, 須田剛生, 坂本直哉
- Organizer
  第５８回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-22K08023
[Presentation] 肝癌intermediate stageの治療戦略　Intermediate stage肝癌に対するLenvatinib+TACE療法の可能性2022
- Author(s)
  荘拓也, 須田剛生, 坂本直哉
- Organizer
  第５８回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-22K08023
[Presentation] 肝疾患病態解明のための細胞生物学的アプローチ　肝細胞癌幹細胞維持機構の解析2022
- Author(s)
  須田剛生, 大原正嗣, 坂本直哉
- Organizer
  第５８回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-22K08023
[Presentation] 肝癌に対する新世代マイクロ波凝固療法の治療成績2022
- Author(s)
  中井正人, 吉田苑永, 細田峻一, 久保彰則, 得地祐匡, 北潟谷隆, 山田錬, 重沢拓,荘拓也, 須田剛生, 森川賢一, 小川浩司, 坂本直哉.
- Organizer
  第130回日本消化器病学会北海道地方会
- Data Source
  KAKENHI-PROJECT-20K08371
[Presentation] 進行肝癌の薬物治療の課題と展望　切除不能肝細胞癌に対するアテゾリズマブ+ベバシズマブ治療早期PD予測因子の探索2022
- Author(s)
  細田峻一, 須田剛生, 坂本直哉
- Organizer
  第５８回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-22K08023
[Presentation] 再活性化が疑われた急性E型肝炎の1例2022
- Author(s)
  久保彰則, 小川浩司, 吉田苑永, 細田峻一, 得地祐匡, 北潟谷隆, 山田錬, 重沢拓, 中井正人, 荘拓也, 須田剛生, 森川賢一, 石田勢津子, 坂本直哉
- Organizer
  第130回日本消化器病学会北海道地方会
- Data Source
  KAKENHI-PROJECT-20K08371
[Presentation] 肝硬変体液貯留に対するトルバプタン投与症例における尿NGAL測定の有用性2022
- Author(s)
  中井正人, 森川賢一, 吉田苑永, 細田峻一, 久保彰則, 得地祐匡, 北潟谷隆, 山田錬, 大原正嗣, 荘拓也, 須田剛生, 小川浩司, 坂本直哉
- Organizer
  第５８回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-22K08023
[Presentation] 当院における切除不能肝細胞癌に対するアテゾリズマブ＋ベバシズマブ療法の使用経験2021
- Author(s)
  吉田苑永, 荘拓也, 久保彰則, 得地祐匡, 細田峻一, 北潟谷隆, 山田錬, 中井正人,須田剛生, 森川賢一, 小川浩司, 坂本直哉
- Organizer
  第129回日本消化器病学会北海道地方会
- Data Source
  KAKENHI-PROJECT-20K08371
[Presentation] Lenvatinib加療後にCRに至りconversion surgeryを施行した肝内多発転移を伴う肝細胞癌の1例2021
- Author(s)
  細田峻一, 中井正人, 吉田苑永, 久保彰則, 得地祐匡, 北潟谷隆, 山田錬, 荘拓也, 須田剛生, 森川賢一, 小川浩司, 坂本直哉, 岡崎ななせ, 大塚拓也, 三橋智子
- Organizer
  第129回日本消化器病学会北海道地方会
- Data Source
  KAKENHI-PROJECT-20K08371
[Presentation] 部分的脾動脈塞栓術(PSE), バルーン閉塞下逆行性経静脈的塞栓術(BRTO)の肝予備能, 線維化マーカー, 予後への影響2021
- Author(s)
  5.中井正人, 小川浩司, 坂本直哉, 久保彰則, 得地祐匡, 北潟谷隆, 山田錬, 重沢拓, 荘拓也, 須田剛生, 森川賢一
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08371
[Presentation] 肝疾患患者における筋肉量の経時変化の評価はBIA法に比べCT画像を用いた方法が有用である2021
- Author(s)
  大原正嗣, 須田剛生, 重沢拓, 鈴木和治, 中村晃久, 川岸直樹, 中井正人, 荘拓也,小川浩司, 森川賢一, 坂本直哉
- Organizer
  第57回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08371
[Presentation] ストレス応答よりみえてくるB型およびC型肝炎ウイルスの戦略2020
- Author(s)
  森川賢一, 須田剛生, 坂本直哉.
- Organizer
  第56回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-20K08371
[Presentation] Long-term effect of nucleos(t)ide analogs on hepatitis B surface antigen in chronic hepatits B patients.2019
- Author(s)
  1.Morikawa K, Umemura M, Ogawa K, Shigesawa T, Suzuki K, Nakamura A, Ohara M, Kawagishi N, Shimazaki T, Kimura M, Izumi T, Nakai M, Sho T, Suda G, Natsuizaka M, Ono K, Murata K, Sugiyama M, Mizokami M, Sakamoto N.
- Organizer
  The European Association for the Study of the Liver (EASL) International Liver Congress.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] Risk assessment of hepatocellular carcinoma in chronic liver disease patients with a combination of liver stiffness measurement and controlled attenuation parameter by FibroScan.2018
- Author(s)
  Morikawa K, Izumi T, Sho T, Suzuki K, Nakamura A, Ohara M, Kawagishi N, Umemura M, Nakai M, Suda G, Ogawa K, Kudo Y, Nishida M, Baba M, Furuya K, Sakamoto N.
- Organizer
  The European Association for the Study of the Liver (EASL) International Liver Congress.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] Changes in liver steatosis and lipid metabolism accompanied by successful interferon-free DAAs therapy in HCV infected patients; a comprehensive analysis.2018
- Author(s)
  Kawagishi N, Suda G, Morikawa K, Ogawa K, Sakamoto N.
- Organizer
  The European Association for the Study of the Liver (EASL) International Liver Congress.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] Clinical phase 1b study results for safety, pharmacokinetics and efficacy of ND-L02-s0201, a novel targeted lipid nanoparticle delivering HSP47 SIRNA for the treatment of Japanese patients with advanced liver fibrosis.2018
- Author(s)
  Sakamoto N, Ogawa K, Morikawa K, Suda G, Sho T, Nakai M, Suzuki H, Yamagata N, Tanaka Y, Ying W, Tamura Y, Niitsu Y, Maruyama K.
- Organizer
  he European Association for the Study of the Liver (EASL) International Liver Congress.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] Prevalence and risk factors of hepatitis B virus reactivation in interferon-free direct-acting antiviral therapies for hepatitis C.2017
- Author(s)
  Kawagishi N, Suda G, Onozawa M, Kimura M, Maehara O, Ohara M, Izumi T, Umemura M, Ito J, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N.
- Organizer
  The European Association for the Study of the Liver (EASL) International Liver Congress. (Amsterdam, Netherlands)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] Influence of hepatitis B virus genotypes on innate immune response by impairing Mitochondrial Antiviral Signaling Protein.2017
- Author(s)
  Umemura M, Morikawa K, Ando S, Takeda R, Izumi T, Shimazaki T, Kawagishi N, Ohara M, Ito J, Nakai M, Sho T, Suda G, Ogawa K, Sakamoto N.
- Organizer
  The Asian Pacific Association for the Study of the Liver (APASL) Single Topic Conference. (Nagasaki, Japan)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] Hepatitis B virus X protein modulates host restriction factor via interaction with DDB1.2017
- Author(s)
  Izumi T, Morikawa K, Ando S, Takeda R, Umemura M, Shimazaki T, Kawagishi N, Ohara M, Ito J, Nakai M, Sho T, Suda G, Ogawa K, Sakamoto N.
- Organizer
  The Asian Pacific Association for the Study of the Liver (APASL) Single Topic Conference. (Nagasaki, Japan)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] Hepatitis B virus infected cell slows down its cell cycle and proliferation by viral protein and replication.2017
- Author(s)
  Morikawa K, Shimazaki T, Izumi T, Umemura M, Nakai M, Suda G, Sakamoto N.
- Organizer
  The European Association for the Study of the Liver (EASL) International Liver Congress. (Amsterdam, Netherlands)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09400
[Presentation] 肝硬変患者に対するカルニチン製剤の有用性の検討2015
- Author(s)
  小川浩司,梅村真知子,出水孝章,伊藤淳,常松聖司,佐藤史幸,中井正人,荘拓也,須田剛生,森川賢一,坂本直哉.
- Organizer
  第117回日本消化器病学会北海道支部例会
- Place of Presentation
  札幌コンベンションセンター（北海道　札幌市）
- Year and Date
  2015-08-29
- Data Source
  KAKENHI-PROJECT-15K08980
[Presentation] Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reaction2014
- Author(s)
  Goki Suda1 ,Yoko Tsukuda1, Seiji Tsunematsu1, Fumiyuki Satou1, Katsumi Terasita1, Takuya Sho 1, Masato Nakai1, Mitsuteru Natsuizka1, Makoto Chuma 1, Naoya Sakamoto
- Organizer
  65th. Annual Meeting of American Association for the Study of Liver Diseases
- Place of Presentation
  Boston (USA)
- Year and Date
  2014-11-09
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] Ｃ型肝炎は完治できる時代へ2014
- Author(s)
  須田剛生
- Organizer
  日本臨床検査医学学術集会
- Place of Presentation
  福岡国際会議場　（福岡県　博多）
- Year and Date
  2014-11-24
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] C型慢性肝炎に対するDAA療法の治療予測因子・薬剤耐性ウイルスの検討2014
- Author(s)
  須田剛生　中馬誠坂本直哉
- Organizer
  肝臓病学会総会
- Place of Presentation
  ホテルニューオータニ　（東京都　千代田区)
- Year and Date
  2014-05-29
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] プロテアーゼ阻害剤併用療法の治療予測因子・薬剤耐性ウイルスの検討2014
- Author(s)
  須田剛生　中馬誠坂本直哉
- Organizer
  消化器病学会総会
- Place of Presentation
  東京国際フォーラム (東京都　千代田区）
- Year and Date
  2014-04-24
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] Analysis of First and Second Generation Protease Inhibitor Combination Therapy in Patients with Chronic Hepatitis C Virus Infection2014
- Author(s)
  須田剛生　永坂敦坂本直哉
- Organizer
  日本消化器病関連学会週間
- Place of Presentation
  神戸国際展示場　（兵庫県　神戸）
- Year and Date
  2014-10-23
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] DAA併用療法におけるDAA耐性ウイルス/治療予測因子の検討2014
- Author(s)
  須田剛生　古家乾　坂本直哉
- Organizer
  肝臓病学会東部会
- Place of Presentation
  京王プラザホテル　（東京　新宿）
- Year and Date
  2014-11-29
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] Serum granulysin level is correlated with severity of telaprevir induced dermatological adverse reactions and could be a useful predictor2014
- Author(s)
  Goki Suda , Yoshiya Yamamoto, Astusi Nagasaka, Ken Furuya, Yoko Tsukuda, Seiji Tsunematsu, Fumiyuki Satou, Katsumi Terasita, Keita Horimoto, Takuya Sh Masato Nakai, Mitsuteru Natsuizka, Makoto Chuma , Naoya Sakamoto
- Organizer
  Asian Pacific Association for The Study of the Liver
- Place of Presentation
  Brisbane Convention & Exhibition Centre（Brisbene）, Australia
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] Telaprevir/Peg-IFN/RBV3剤併用療法の治療効果および副作用予測因子の解析2013
- Author(s)
  須田剛生　中馬誠　坂本直哉
- Organizer
  日本消化器病関連学会週間
- Place of Presentation
  グランドプリンス高輪ホテル（東京）
- Data Source
  KAKENHI-PROJECT-25860513
[Presentation] Establishment of Interferon resistant genotype 2b/JFH-1 chimeric Hepatitis C virus cell culture system2013
- Author(s)
  Goki Suda, Yoko Tsukuda, Mitsuteru Natsuizaka, Makoto Chuma, Naoya Sakamoto
- Organizer
  64th. Annual Meeting of American Association for the Study of Liver Diseases
- Place of Presentation
  Walter E. Washington Convention Center　（Wachington DC）, USA
- Data Source
  KAKENHI-PROJECT-25860513

1. SAKAMOTO Naoya (10334418)

# of Collaborated Projects: 18 results

# of Collaborated Products: 81 results
2. Morikawa Kenichi (60384377)

# of Collaborated Projects: 7 results

# of Collaborated Products: 51 results
3. 古川潤一 (30374193)

# of Collaborated Projects: 4 results

# of Collaborated Products: 3 results
4. 大西俊介 (10443475)

# of Collaborated Projects: 3 results

# of Collaborated Products: 3 results
5. koji ogawa (20735188)

# of Collaborated Projects: 2 results

# of Collaborated Products: 8 results
6. Sho Takuya (50581104)

# of Collaborated Projects: 2 results

# of Collaborated Products: 2 results
7. ENDO TOSHINORI (00323692)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 武井則雄 (50523461)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 夏井坂光輝 (80642446)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results
10. 前原経 (80836338)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
11. 小松嘉人 (60333598)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
12. 川久保和道 (80633578)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 西田奈央 (50456109)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 大橋順 (80301141)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. YUYAMA Kohei

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
16. TSUMOTO Hiroki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
17. KUDO Masatoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. ASAHINA Yasuhiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
19. 川岸直樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
20. 西田直生志

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
21. 大原正嗣

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
22. 中井正人

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
23. 橋本大吾

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
24. 中西満

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Suda Goki 須田 剛生

SUDA Goki 須田 剛生

Research Projects

Research Products

Co-Researchers

新規肝癌腫瘍免疫逃避機構・免疫チェックポイント阻害剤耐性化機構の解明と治療応用Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肝線維化治療標的同定とそれに基づく新規抗肝線維化治療法開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

High through anti-HBV drug screening by using reporter assayPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Suda Goki 須田剛生

SUDA Goki 須田剛生